stockrowBioNexus Gene Lab Corp. (BGLC) vs Northern Technologies International Corporation (NTIC)
- BioNexus Gene Lab Corp. BGLC 0.83 −3.49%
- Northern Technologies International Corporation NTIC 7.45 −1.72%
BioNexus Gene Lab Corp. and Northern Technologies International Corporation are both Specialty Chemicals companies. Northern Technologies International Corporation is the larger, with a market value of $70.8M against $2.4M — 29.1× the size. Northern Technologies International Corporation grew revenue faster over the last twelve months: 7.70% against −67.3%. Northern Technologies International Corporation has the higher net margin (−1.26% vs −82.4%) and the higher return on invested capital (2.03% vs −37.2%). Across the 19 metrics below, Northern Technologies International Corporation leads on 12 and BioNexus Gene Lab Corp. on 7.
Valuation
Profitability
| Metric | BGLC | NTIC | Specialty Chemicals median |
|---|---|---|---|
| Gross margin | 12.34% | 35.76% | 27.84% |
| Operating margin | (79.62%) | 3.01% | 5.64% |
| Net margin | (82.36%) | (1.26%) | 4.26% |
| Free cash flow margin | (27.30%) | (4.28%) | 4.75% |
| Return on equity | (33.66%) | (1.51%) | 3.73% |
| Return on assets | (28.38%) | (1.12%) | 1.16% |
| Return on invested capital | (37.16%) | 2.03% | 3.21% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack